Valeant Pharmaceuticals International Inc (NYSE:VRX)

Data as of Jan 29
 +0.92 / +0.57%
Today’s Change
Today|||52-Week Range

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Quarter 4
Quarter 1
Quarter 2
Quarter 3
Revenue and IncomeNet Revenues2.1B1.9B2.0B2.1B
Operating ExpensesGross Income954.1M1.0B1.1B1.1B
Other Operating Expenses174.2M0.000.000.00
Total Operating Expenses1.8B1.4B1.5B1.5B
Non-Operating ExpensesOperating Income270.1M469.3M507.7M571.5M
Extraordinary Credit0.0043.3M----
Extraordinary Charge-71.9M-249.7M-153.0M-119.6M
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-78.1M4.8M121.0M376.7M
Income Taxes-203.1M-25.1M-1.0M-100.3M
Minority Interest-1.2M-2.3M-3.8M-1.0M
Net Income123.8M-22.6M125.8M275.4M
Shares To Calculate EPSShares To Calculate EPS334.4M334.9M335.3M335.4M
Shares To Calculate EPS Diluted340.9M334.9M341.3M341.3M
Earnings Per ShareEPS$0.37-$0.07$0.38$0.82
EPS Diluted----------

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.